Arcadia Biosciences (RKDA) Depreciation & Amortization (CF) (2014 - 2025)

Arcadia Biosciences (RKDA) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $2000.0 in Q4 2025.

• Quarterly Depreciation & Amortization (CF) rose 105.88% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32000.0 (down 44.83% YoY) and the FY2025 annual result came in at $32000.0, down 44.83% from the prior year.
• Depreciation & Amortization (CF) was little changed at $2000.0 in Q4 2025, from $2000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $253000.0 in Q3 2021 to a low of -$116000.0 in Q4 2023.
• A 5-year average of $76550.0 and a median of $61000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 218.92% — and 2023, when it tumbled 236.47%.
• Tracing RKDA's Depreciation & Amortization (CF) over 5 years: stood at $192000.0 in 2021, then sank by 55.73% to $85000.0 in 2022, then plunged by 236.47% to -$116000.0 in 2023, then surged by 70.69% to -$34000.0 in 2024, then jumped by 105.88% to $2000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $2000.0 (Q4 2025), $2000.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.